US 10533040
Colon and pancreas cancer peptidomimetics
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 10533040 (Colon and pancreas cancer peptidomimetics) held by PRECISION BIOLOGICS, INC. expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PRECISION BIOLOGICS, INC.
- Grant date
- Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61K39/0011, A61K45/06